Risk of infections in patients with nafld and type 2 diabetes under treatment with sglt2 inhibitors and relationship with liver outcomes: a retrospective case-control study

HIGHLIGHTS

• who: Juan Bau00f1ares et al. from the Federal University of Rio de Janeiro, Brazil have published the paper: Risk of infections in patients with NAFLD and Type 2 Diabetes under treatment with SGLT2 inhibitors and relationship with liver outcomes: A retrospective case-control study, in the Journal: (JOURNAL)
• what: The authors aimed to examine the possible association of SGLT2i with infections and hepatic outcomes in NAFLD patients. Despite the limitations , the authors provide data about infectious and metabolic outcomes that are relevant to clinical practice.
• how: The authors conducted a case-control study . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.